wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37520635-71B747A3-E8C9-47ED-9E47-EB752123D5A1
Q37520635-71B747A3-E8C9-47ED-9E47-EB752123D5A1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37520635-71B747A3-E8C9-47ED-9E47-EB752123D5A1
Hepatocellular carcinoma cases with high levels of c-Raf-1 expression may benefit from postoperative adjuvant sorafenib after hepatic resection even with high risk of recurrence.
P2860
Q37520635-71B747A3-E8C9-47ED-9E47-EB752123D5A1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37520635-71B747A3-E8C9-47ED-9E47-EB752123D5A1
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d754ebf02eee34394a7a620c5895913d32bca168
P2860
Safety and efficacy of sorafenib for the treatment of recurrent hepatocellular carcinoma after liver transplantation.